BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

489 related articles for article (PubMed ID: 29199370)

  • 1. Measuring medication adherence in older community-dwelling patients with multimorbidity.
    Kim S; Bennett K; Wallace E; Fahey T; Cahir C
    Eur J Clin Pharmacol; 2018 Mar; 74(3):357-364. PubMed ID: 29199370
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying Adherence Patterns Across Multiple Medications and Their Association With Health Outcomes in Older Community-Dwelling Adults With Multimorbidity.
    Walsh CA; Bennett KE; Wallace E; Cahir C
    Value Health; 2020 Aug; 23(8):1063-1071. PubMed ID: 32828219
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of Patient Medication Adherence, Medical Record Accuracy, and Medication Blood Concentrations for Prescription and Over-the-Counter Medications.
    Sutherland JJ; Morrison RD; McNaughton CD; Daly TM; Milne SB; Daniels JS; Ryan TP
    JAMA Netw Open; 2018 Nov; 1(7):e184196. PubMed ID: 30646345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Medication adherence in community-dwelling older people exposed to chronic polypharmacy.
    Franchi C; Ardoino I; Ludergnani M; Cukay G; Merlino L; Nobili A
    J Epidemiol Community Health; 2021 Sep; 75(9):854-859. PubMed ID: 33500324
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medication adherence, healthcare costs and utilization associated with acne drugs in Medicaid enrollees with acne vulgaris.
    Tan X; Al-Dabagh A; Davis SA; Lin HC; Balkrishnan R; Chang J; Feldman SR
    Am J Clin Dermatol; 2013 Jun; 14(3):243-51. PubMed ID: 23572294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing a model of the determinants of medication nonadherence in older community-dwelling patients.
    McLoughlin A; Bennett K; Cahir C
    Ann Behav Med; 2019 Oct; 53(11):942-954. PubMed ID: 30870558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of a complex intervention on Prioritising Multimedication in Multimorbidity (PRIMUM) in primary care: results of a pragmatic cluster randomised controlled trial.
    Muth C; Uhlmann L; Haefeli WE; Rochon J; van den Akker M; Perera R; Güthlin C; Beyer M; Oswald F; Valderas JM; Knottnerus JA; Gerlach FM; Harder S
    BMJ Open; 2018 Feb; 8(2):e017740. PubMed ID: 29478012
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Supporting prescribing in older people with multimorbidity and significant polypharmacy in primary care (SPPiRE): a cluster randomised controlled trial protocol and pilot.
    McCarthy C; Clyne B; Corrigan D; Boland F; Wallace E; Moriarty F; Fahey T; Hughes C; Gillespie P; Smith SM
    Implement Sci; 2017 Aug; 12(1):99. PubMed ID: 28764753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Longitudinal Medication Adherence in Older Adults With Multimorbidity and Association With Health Care Utilization: Results From the Irish Longitudinal Study on Ageing.
    Walsh CA; Cahir C; Bennett KE
    Ann Pharmacother; 2021 Jan; 55(1):5-14. PubMed ID: 32608252
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Medication Adherence and Related Outcomes in Community-Dwelling Older People on Chronic Polypharmacy: A Retrospective Cohort Study on Administrative Claims Data.
    Franchi C; Ludergnani M; Merlino L; Nobili A; Fortino I; Leoni O; Ardoino I
    Int J Environ Res Public Health; 2022 May; 19(9):. PubMed ID: 35565087
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of number of medications and age on adherence to antihypertensive medications: A nationwide population-based study.
    Kim SJ; Kwon OD; Han EB; Lee CM; Oh SW; Joh HK; Oh B; Kwon H; Cho B; Choi HC
    Medicine (Baltimore); 2019 Dec; 98(49):e17825. PubMed ID: 31804305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Deprescribing interventions and their impact on medication adherence in community-dwelling older adults with polypharmacy: a systematic review.
    Ulley J; Harrop D; Ali A; Alton S; Fowler Davis S
    BMC Geriatr; 2019 Jan; 19(1):15. PubMed ID: 30658576
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of asthma medication adherence rates and strategies to improve adherence in the underserved population at a Federally Qualified Health Center.
    Bidwal M; Lor K; Yu J; Ip E
    Res Social Adm Pharm; 2017; 13(4):759-766. PubMed ID: 27595427
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Assessing adherence to multiple medications and in daily life among patients with multimorbidity.
    Inauen J; Bierbauer W; Lüscher J; König C; Tobias R; Ihle A; Zimmerli L; Holzer BM; Battegay E; Siebenhüner K; Kliegel M; Scholz U
    Psychol Health; 2017 Oct; 32(10):1233-1248. PubMed ID: 28043163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Polypharmacy and Adherence to Adjuvant Endocrine Therapy for Breast Cancer.
    Calip GS; Xing S; Jun DH; Lee WJ; Hoskins KF; Ko NY
    J Oncol Pract; 2017 May; 13(5):e451-e462. PubMed ID: 28287854
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adherence to oral antidiabetic medications in the pediatric population with type 2 diabetes: a retrospective database analysis.
    Adeyemi AO; Rascati KL; Lawson KA; Strassels SA
    Clin Ther; 2012 Mar; 34(3):712-9. PubMed ID: 22381712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Changes in prescription patterns in older hospitalized patients: the impact of FORTA on disease-related over- and under-treatments.
    Pazan F; Burkhardt H; Frohnhofen H; Weiss C; Throm C; Kuhn-Thiel A; Wehling M
    Eur J Clin Pharmacol; 2018 Mar; 74(3):339-347. PubMed ID: 29196825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of Employer-Sponsored Onsite Pharmacy and Condition Management Programs on Medication Adherence.
    Aguilar KM; Hou Q; Miller RM
    J Manag Care Spec Pharm; 2015 Aug; 21(8):670-7. PubMed ID: 26233539
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adherence to multiple medications prescribed for a chronic disease: a methodological investigation.
    Basak R; McCaffrey Iii DJ; Bentley JP; Przybyla SM; West-Strum D; Banahan BF
    J Manag Care Spec Pharm; 2014 Aug; 20(8):815-23. PubMed ID: 25062075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparing clinical trial population representativeness to real-world populations: an external validity analysis encompassing 43 895 trials and 5 685 738 individuals across 989 unique drugs and 286 conditions in England.
    Tan YY; Papez V; Chang WH; Mueller SH; Denaxas S; Lai AG
    Lancet Healthy Longev; 2022 Oct; 3(10):e674-e689. PubMed ID: 36150402
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.